Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 94 results found. Search for [ gilead news ]

Results 1 to 21 of 94
BusinessToday.In
April 30, 2021
Gilead will dispatch 75,000 to 1,00,00 vials in the next one or two days. Further, 100,000 will also be supplied before or by May 15. EVA Pharma will supply 10,000 vials initially, followed by 50,000 every 15 days or till July


BusinessToday.In
April 27, 2021
The equity value is an all-cash offer of Rs 3,015 crore for a 96.42% stake in JPL including 3,400 MW coal-fired power plants in the state of Chhattisgarh and other non-core assets owned by JPL.


BusinessToday.In
April 19, 2021
Jubilant Pharma says oral formulation is an affordable, more convenient, easy-to-administer and potentially effective treatment option for COVID-19 patients


BusinessToday.In
April 12, 2021
Stocks in focus in today's trade: TCS, Infosys, Balrampur Chini Mills, Pharma stocks, Barbeque Nation Hospitality and more


BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery


Reuters
November 20, 2020
WHO suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients


Reuters
November 9, 2020
Remdesivir was developed by US drugmaker Gilead Sciences, which cut its 2020 revenue forecast last month, citing lower-than-expected demand and difficulty in predicting sales of treatment


BusinessToday.In
October 26, 2020
Gold, Silver prices today: Gold, viewed as a hedge against inflation and currency debasement has risen over 25% this year, supported by unprecedented monetary stimulus from major central banks


BusinessToday.In
October 26, 2020
India Stock Market Highlights Today: Reliance Industries, followed by Tata Steel, Bajaj Finance, Asian Paints, M&M, ICICI Bank and Bajaj Finserv were among the top laggards in the Sensex pack today. On the other hand, IndusInd Bank, Nestle India, PowerGrid and L&T were among the gainers


Associated Press
October 4, 2020
Donald Trump offered his own assessment of his status Saturday evening in a video from his hospital suite, saying he was beginning to feel better and hoped to \"be back soon.\"


Reuters
October 4, 2020
A White House team of doctors said on Saturday morning that Trump's condition was improving and that he was already talking about returning to the White House


PTI
August 8, 2020
The drug is being made available to over 1,000 hospitals providing COVID-19 treatment in India through the company's distribution network, Jubilant Life Sciences said in a statement


Reuters
July 31, 2020
The indictment states the Chinese hackers \"conducted reconnaissance\" against the computer network of a Massachusetts biotech firm known to be working on a coronavirus vaccine in January


Prasanna Mohanty
July 27, 2020
Profit-driven enterprises are ill-suited to protect the health and life of a vast majority of people, as the US and Indian governments experience, but do precious little, thereby failing in their primary duty


Reuters
July 22, 2020
In results announced last month, a trial by researchers in the United Kingdom showed dexamethasone as the first drug to save lives of COVID-19 patients in what scientists said was a major breakthrough in the coronavirus pandemic


Rajeev Dubey
New Delhi, July 17, 2020
Sharks in the pharma supply chains are stockpiling and black-marketing a key life-saving drug for Covid-19, an India Today investigation has found. Remdesivir, produced by America's Gilead Sciences, is touted as the best hope for critically-ill coronavirus patients for its ability to shorten recovery times in clinical trials. India Today's undercover investigation has found that those who need remdesivir to keep them alive may not be able to afford it because of its excessive pricing on the black market. But, who's at fault? Rajeev Dubey, Editor, Business Today explains.Also Read: Coronavirus vaccine update: COVAXIN human trials start at PGI Rohtak


BusinessToday.In
New Delhi, July 17, 2020
Remdesivir, produced by America's Gilead Sciences, is touted as the best hope for critically-ill coronavirus patients for its ability to shorten recovery times in clinical trials.Gilead has licensed several drugmakers in India to make its generic versions. India Today's undercover investigation has found that those who need remdesivir to keep them alive may not be able to afford it because of its excessive pricing on the black market.


PTI
July 15, 2020
Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease


BusinessToday.In
July 13, 2020
Stock Market LIVE Updates on July 13: RIL, Infosys, Tech Mahindra, Tata Steel, IndusInd Bank, HUL and Maruti were among the other gainers on Sensex pack today. On the other hand, Bharti Airtel and HDFC were among the top laggards


BusinessToday.In
July 10, 2020
Coronavirus vaccine news update: Serum Institute of India that is producing around four vaccine candidates including the Oxford University-AstraZeneca coronavirus candidate has said that it is expected to launch a candidate by the end of six months


PAGES 1 OF 5  12345